Want to see HK:2228 full AI Analyst Report?
2228 Stock Chart & Stats
HK$10.45
-HK$0.15(-3.03%)
At close: 4:00 PM EST
HK$10.45
-HK$0.15(-3.03%)
Day’s Range― - ―
52-Week RangeHK$5.67 - HK$15.12
Previous CloseN/A
Volume31.51M
Average Volume (3M)143.30M
Market Cap
HK$30.88B
Enterprise ValueHK$32.65K
Total Cash (Recent Filing)HK$7.07B
Total Debt (Recent Filing)HK$443.46M
Price to Earnings (P/E)192.7
Beta0.93
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding4,303,469,700
10 Day Avg. Volume160,836,692
30 Day Avg. Volume143,301,077
Financial Highlights & Ratios
PEG Ratio-2.56
Price to Book (P/B)3.42
Price to Sales (P/S)41.11
P/FCF Ratio-160.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$11.42Price Target Upside9.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)HK$998.59M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthXtalPi leverages its proprietary AI-powered R&D platform to deliver stable and accelerating revenue growth across two core business areas: drug discovery and intelligent robotics.
Strategic PartnershipsXtalPi's expanding ecosystem of partnerships reflects its strong commercialization potential across AI and robotics-enabled industries.
Bears Say
R&D Pipeline RisksRisks include potential delays in partnered R&D pipelines, uncertainty in commercialization sustainability, and possible sell-off following lock-up expiry.
QuantumPharm, Inc. News
2228 FAQ
What was QuantumPharm, Inc.’s price range in the past 12 months?
QuantumPharm, Inc. lowest stock price was HK$5.67 and its highest was HK$15.12 in the past 12 months.
What is QuantumPharm, Inc.’s market cap?
QuantumPharm, Inc.’s market cap is HK$30.88B.
When is QuantumPharm, Inc.’s upcoming earnings report date?
QuantumPharm, Inc.’s upcoming earnings report date is Sep 02, 2026 which is in 43 days.
How were QuantumPharm, Inc.’s earnings last quarter?
QuantumPharm, Inc. released its earnings results on Mar 27, 2026. The company reported HK$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is QuantumPharm, Inc. overvalued?
According to Wall Street analysts QuantumPharm, Inc.’s price is currently Undervalued.
Does QuantumPharm, Inc. pay dividends?
QuantumPharm, Inc. pays a Notavailable dividend of HK$0.007 which represents an annual dividend yield of N/A. See more information on QuantumPharm, Inc. dividends here
What is QuantumPharm, Inc.’s EPS estimate?
QuantumPharm, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QuantumPharm, Inc. have?
QuantumPharm, Inc. has 4,303,469,700 shares outstanding.
What happened to QuantumPharm, Inc.’s price movement after its last earnings report?
QuantumPharm, Inc. reported an EPS of HK$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.56%.
Which hedge fund is a major shareholder of QuantumPharm, Inc.?
Currently, no hedge funds are holding shares in HK:2228
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
QuantumPharm, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.62%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
145.56%
Trailing 12-Months
Company Description
QuantumPharm, Inc.
XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
2228 Stock 12 Month Forecast
Average Price Target
HK$11.42
▲(9.28% Upside)
Technical Analysis
Alibaba Health Information Technology
―
Ping An Healthcare and Technology Company
―
Beijing Health (Holdings) Limited
―
Yidu Tech, Inc.
―
Xunfei Healthcare Technology Co., Ltd.
―